Table 1 Clinical characteristics
From: Omentin as a novel biomarker of metabolic risk factors
Parameters | Subjects (n = 201) |
|---|---|
Age (years) | 53.9 ± 9.0 |
BMI (kg/m2) | 23.3 ± 2.6 |
Waist circumference (cm) | 84.7 ± 6.8 |
Systolic BP (mmHg) | 116.6 ± 17.6 |
Diastolic BP (mmHg) | 72.9 ± 12.1 |
Fasting glucose (mg/dl) | 103.6 ± 12.4 |
Hemoglobin A1c (%) | 5.06 ± 0.53 |
Fasting insulin (μIU/ml) | 5.82 ± 3.8 |
Total cholesterol (mg/dl) | 204.0 ± 34.8 |
LDL cholesterol (mg/dl) | 110.7 ± 25.8 |
HDL cholesterol (mg/dl) | 55.3 ± 13.8 |
Triglyceride (mg/dl) | 137.2 ± 75.6 |
Creatinine (mg/dl) | 0.87 ± 0.13 |
Log hsCRP (mg/dl) | 2.63 ± 0.44 |
Log omentin (ng/ml) | 2.66 ± 0.01 |